A new study published in Neurological Research and Practice finds that off-label use of cannabidiol (CBD) in patients with ...

New research suggests that delivering cannabidiol (CBD) through the nasal cavity using nanostructured lipid carriers (NLCs) may improve its effectiveness in treating epilepsy. Published in Molecular ...